GNRH1 and endometriosis: These data showed clearly that in patients with adenomyosis undergoing GnRH agonist pretreatment before FET, cumulative LBRs were not inferior in patients aged < 38 years but were significantly lower in those aged ≥ 38 years, compared with the control and endometriosis groups.